Grant News
Cure Parkinson’s is accepting applications to its Quarterly Research Grant Funding Programme for preclinical and clinical research aimed at slowing, stopping or reversing Parkinson’s progression. The charity funds research internationally and focuses on treatments with realistic potential to benefit people living with Parkinson’s. Cure Parkinson's
Funding is available to academic researchers and commercial organisations, working independently or collaboratively. Preclinical projects can receive up to £300,000 for up to 36 months. Clinical infrastructure projects and sub-studies typically receive £75,000 to £300,000, while clinical trial awards depend on the trial stage. Cure Parkinson's
Key points / Highlights:
- International applications are eligible.
- Clinical studies must involve people with Parkinson’s.
- Preclinical projects must have a clinical candidate and potential to reach clinical testing within five years.
- Symptomatic relief, basic science, observational studies and early-stage drug discovery are excluded.
Applications follow a two-stage process, with shortlisted proposals undergoing external peer review. The current Stage 1 deadline is 18 January 2027 at 23:59 BST. Further deadlines are scheduled quarterly.
Useful Links:
Application Hints and Tips (AI Generated)
Related news:
Funding Available to Tackle Major Challenges in Parkinson’s Research (UK)